Skip to main content

Medullary ischemia after endovascular procedure of infrarenal aorta in a patient with dual anticoagulant and antiplatelet therapy: a case report



Medullary ischemia secondary to surgical procedures of the infrarenal aorta is an infrequent and mostly devastating complication of this procedure, and its nonspecific clinical presentation makes it difficult to promptly diagnose. Prevention measures for this complication are not yet clear; therefore, the need for anticoagulant and/or antiplatelet therapy is discussed.

Case presentation

This paper reports a case of a 69-year-old Hispanic man presenting with sudden pain and signs of ischemia on his left lower extremity 8 weeks after endovascular repair with endoprosthesis of an infrarenal aorta and left iliac aneurysm. The patient was admitted to the emergency room, where an extensive arterial thrombosis compromising the right iliac and femoral arteries was diagnosed. Dual anticoagulation and antiplatelet therapies were initiated, and therapeutic ranges were achieved. Nonetheless, the patient presented medullary ischemia by microembolization diagnosed by contrast-enhanced magnetic resonance imaging, with unsatisfactory evolution of an intracranial hemorrhagic event without documented excessive anticoagulation. The patient developed permanent pure motor deficit of his lower extremities, absence of sphincter control, and mild cognitive impairment.


This is a complex and extremely rare case. It is important to continue with clinical investigations that give more clarity about the onset of anticoagulation, antiplatelet therapy, and management of dual schemes to decrease the risk of complications in this type of surgical procedure.

Peer Review reports


Medullary ischemia secondary to surgical procedures of the infrarenal aorta has been reported in the literature as an infrequent complication; however, when present, it can be catastrophic [1]. The diagnosis of this complication is mostly clinical and achieved with the aid of imaging [2]. In several reviews in the literature, it is considered that this event may be preventable with adequate postoperative care; however, the need for anticoagulant and/or antiplatelet therapy is discussed in several clinical studies [3]. Despite not having a clear indication, it is thought that in certain patients it is necessary to consider prescribing at least one antiplatelet medication in order to reduce prothrombotic risks [4]. This paper reports the case of a 69-year-old man who underwent an endovascular repair of an infrarenal aorta and left iliac aneurysm, and even after receiving anticoagulant and antiplatelet therapy, both within therapeutic ranges, he had multiple thromboembolic, ischemic, and hemorrhagic complications 8 weeks after his surgery, with permanent sequelae.

Case presentation

The patient was a 69-year-old Hispanic man with no family history of cardiovascular or hematological diseases. He was a heavy smoker with a history of 15 pack-years. He was retired and not an alcoholic. He had a history of arterial hypertension, revascularized ischemic heart disease, and aortic valve replacement 10 years earlier, in addition to five coronary stents, chronic peripheral arterial disease of the lower limbs, and an aneurysm of the infrarenal aorta and left primitive iliac artery (Fig. 1a, b). He underwent endovascular surgery with an Endurant II stent (Medtronic, Minneapolis, MN, USA) and a successful right hypogastric artery embolization (Fig. 2a–d). There were no complications in the postoperative period; he received ambulatory anticoagulant therapy with low-molecular-weight heparin and subsequent change to warfarin, but with little adherence to the initial treatment. In addition, he received atorvastatin 40 mg daily, acetaminophen 1 g every 8 hours, clonidine 150 mg every 8 hours, losartan 50 mg every 12 hours, nimodipine 60 mg every 4 hours, phenytoin 300 mg/night, and bisacodyl 10 mg daily. He did not receive any antibiotics before the surgery; after the surgery, he received norfloxacin 400 mg every 12 hours for 7 days to treat a urinary tract infection.

Fig. 1
figure 1

a Abdominal computed tomographic (CT) scan in transverse section prior to endovascular surgery. An infrarenal aortic aneurysm is observed. b CT angiography showing infrarenal aortic aneurysm

Fig. 2
figure 2

a Abdominal computed tomography transverse section after endovascular surgery. Endovascular prosthesis implantation is observed. b Aneurysmal stent implantation is observed. c Coronal section with implantation of prosthesis. d Sagittal section with implant of prosthesis. The prosthesis is marked with white arrows

Two months after surgery, he was admitted to the emergency room with blood pressure of 97/52 mmHg, heart rate 79 beats/minute, respiratory rate 20 breaths/minute, and temperature of 36 °C. He presented with sudden pain in his lower left limb with signs of ischemia (absence of popliteal and pedis pulses, paleness and coldness of the extremity, motor and sensitivity loss), a partially normal neurological examination regarding orientation, with compromise of superficial and deep sensitivity of the lower limbs. He had laboratory test results of white blood cell count of 15,2 x10^3/uL, neutrophils 82%, lymphocytes 17%, hemoglobin 15.2 g/dL, hematocrit 44.5%, platelets 154 x10^3/uL, blood urea nitrogen 14.3 mg/dL, creatinine 0.87 mg/dL, and initial international normalized ratio (INR) in subtherapeutic range (INR 1.05–1.95). He was diagnosed with an exacerbation of his chronic peripheral arterial disease with an arterial duplex of his lower limbs, showing moderate atheromatous process of lower limb arteries, with acute left femoral popliteal artery occlusion from its origin extending to the anterior and posterior tibial arteries and pedis artery. The patient was initiated on intravenous unfractionated heparin (UFH) and dual antiplatelet therapy achieving anticoagulation goals with subsequent gradual improvement of limb ischemia. After 48 hours of observation, he had a sudden pain in his lumbar region associated with absence of sphincter control and loss of strength of his lower limbs with a Medical Research Council scale score of 0/5 (complete paralysis). Contrast-enhanced magnetic resonance imaging (MRI) was performed, which revealed extensive dorsal myelopathy from T3–T4 to T11–T12 (Fig. 3a–d) of compressive and/or ischemic nature, and extensive spinal cord infarction was determined. Twenty-four hours later, despite the established antihypertensive treatment, he presented with a hypertensive emergency with acute target organ damage. Anti-ischemic management was initiated, and it was decided to stop heparin due to possible excessive anticoagulation. During the evolution of this presentation, he had headaches; hence, cerebral computed tomographic angiography was performed, which showed supra- and infratentorial intraparenchymal hemorrhage and thalamic hematoma. An intensive care unit stay as well as rehabilitation for the subsequent management of his symptoms and stabilization of comorbidities was required.

Fig. 3
figure 3

a Magnetic resonance imaging (MRI) T2-weighted transverse section. A hyperintensity zone is observed showing spinal infarction at the T10 level. b MRI T1-weighted hypointensity showing spinal cord infarction. c MRI T2-weighted sagittal section showing extension of the medullary infarction with hyperintensity zone. d MRI T1-weighted image showing extension of the medullary infarction with hypointensity zone. The area of infarction is indicated by the white arrow

After commonly agreeing with the family, he was discharged for home healthcare planning. When discharged, the patient’s pure motor deficit in his lower extremities persisted, along with absence of sphincter control and presence of mild cognitive impairment, specifically in memory. Seven months after outpatient treatment, with progressive worsening of complications of his disease with depression, recurrent infections, and skin ulcers, the patient died.


A 69-year-old man with multiple comorbidities had an infrarenal aortic aneurysm treated with endovascular surgery and hypogastric artery embolization without complications. He received anticoagulant therapy with little adherence to the treatment. Two months after surgery, he was admitted to the emergency room with an exacerbation of his chronic peripheral arterial disease. Treatment with intravenous UFH and dual antiplatelet therapy achieved anticoagulation goals. However, 48 hours later, he was diagnosed with an extensive dorsal myelopathy of compressive and ischemic nature, as well as an extensive spinal cord infarction, despite the management with dual anticoagulation and antiplatelet therapy, making this case report an important contribution to the medical literature. There is no specific data for patients who undergo this type of endovascular correction; therefore, it is necessary to continue with clinical investigations that provide more clarity about the onset of anticoagulation, antiplatelet management of dual schemes with the purpose of decreasing the risk of complications.

The endovascular treatment for an aortic aneurysm, both thoracic and abdominal, has increased due to the multiple benefits it offers, being a minimally invasive technique that does not require general anesthesia. The costs associated with the intervention are minor, and the intervention can be performed by different specialties such as endovascular surgery or interventional radiology [1]. However, some reports indicate concern with the high probability of generating embolization at any level secondary to the endovascular approach compared with open surgery [5].

Medullary ischemia after a surgical intervention in the infrarenal aorta, according to some cohorts, has an extremely low reported incidence, up to 0.21% [3]; however, in other reports, it has reached 13.8%, increasing if the patient presents with risk factors such as hypotension during surgery [6, 7], history of repair with a previous endoprosthesis, size of the aneurysm, and surgical technique [8]; using minimally invasive strategies such as the use of catheters and other artifacts can have prothrombotic effects [5]. It is believed that neurological damage after an aortic intervention is secondary to hypoxic damage of the spinal cord and the generation of free radicals in addition to reperfusion edema [9].

The clinical presentation of this complication is unspecific. It has been described that patients arrive with symptoms that suggest abdominal disease because many cases start with abdominal pain associated with nausea, vomiting, and low back pain, which confuses the clinical presentation with a wide range of diagnostic possibilities of abdominal origin [10, 11]. Subsequently, the neurological compromise is generated; however, the onset of this compromise is variable [12]. In one case, it was reported that complete paraplegia was established within the first 18 hours of admission to the emergency room [13], and other clinical cases report that the appearance of this complication was later, between 2 and 10 months after the intervention [14, 15].

The diagnosis of this complication is confirmed by imaging, with MRI being the best tool available with a very high specificity [2]; however, not all cases present a visible alteration on the MRI scan, and it should be suspected on the basis of the patient’s clinical presentation [15]. The diagnosis of spinal cord ischemia in a patient undergoing abdominal aneurysm repair with stent placement is an interesting clinical challenge. In our patient’s case, he was not in therapeutic anticoagulation ranges at admission, and despite initiating anticoagulant and antiplatelet treatment obtaining early therapeutic goal values, he finally presented with the ischemic event at the spinal level associated with a hemorrhagic cerebrovascular event.


Several ideal conditions to minimize the risk of complications in patients undergoing this type of procedure have been proposed in the literature; nevertheless, there is no clarity on the need or indications for the use of anticoagulant or antiplatelet therapies with good clinical evidence in this type of patient. However, it is considered that patients should receive treatment with at least one antiplatelet medication after surgery to reduce potential risks associated with it. In this regard, the most frequently used antiplatelet agents, aspirin and clopidogrel, have been discussed because both have shown considerable effects in the reduction of ischemic events [4]. However, there is no specific data for patients who have undergone this type of endovascular correction; therefore, it is necessary to continue with clinical investigations that give more clarity about the onset of anticoagulation and antiplatelet management in dual schemes with the purpose of decreasing the risk of complications.

Availability of data and materials

Data sharing is not applicable to this article, because no datasets were generated or analyzed during the current study.


  1. Maldonado TS, Rockman CB, Riles E, Douglas D, Adelman MA, Jacobowitz GR, Riles TS. Ischemic complications after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2004;40(4):703–10.

    Article  Google Scholar 

  2. Defraigne JO, Otto B, Sakalihasan N, Limet R. Spinal ischaemia after surgery for abdominal infrarenal aortic aneurysm: diagnosis with nuclear magnetic resonance. Acta Chir Belg. 1997;97(5):250–6.

    CAS  PubMed  Google Scholar 

  3. Buth J, Harris PL, Hobo R, van Eps R, Cuypers P, Duijm L, Tielbeek X. Neurologic complications associated with endovascular repair of thoracic aortic pathology: incidence and risk factors. A study from the European Collaborators on Stent/Graft Techniques for Aortic Aneurysm Repair (EUROSTAR) Registry. J Vasc Surg. 2007;46(6):1103–11. e2

    Article  Google Scholar 

  4. Saratzis A, Saratzis N, Melas N, Kiskinis D. Pharmacotherapy before and after endovascular repair of abdominal aortic aneurysms. Curr Vasc Pharmacol. 2008;6(4):240–9.

    Article  CAS  Google Scholar 

  5. Rockman CB, Riles TS, Landis R. Lower extremity paraparesis or paraplegia subsequent to endovascular management of abdominal aortic aneurysms. J Vasc Surg. 2001;33(1):178–80.

    Article  CAS  Google Scholar 

  6. Amato ACM, Stolf NAG, Amato ACM, Stolf NAG. Anatomia da circulação medular. J Vasc Brasileiro. 2015;14(3):248–52.

    Article  Google Scholar 

  7. Wikinski JA, Salgueiro C. The artery of Adamkiewicz and its role in medullar irrigation [in Spanish]. Rev Arg Anest. 2003;61(3):170–81.

  8. Chiesa R, Melissano G, Marrocco-Trischitta MM, Civilini E, Setacci F. Spinal cord ischemia after elective stent-graft repair of the thoracic aorta. J Vasc Surg. 2005;42(1):11–7.

    Article  Google Scholar 

  9. Oudega M. Molecular and cellular mechanisms underlying the role of blood vessels in spinal cord injury and repair. Cell Tissue Res. 2012;349(1):269–88.

    Article  CAS  Google Scholar 

  10. Rodríguez-Baeza A, Muset-Lara A, Rodríguez-Pazos M, Domenech-Mateu JM. Anterior spinal arteries: origin and distribution in man. Acta Anat. 1989;136(3):217–21.

    Article  Google Scholar 

  11. Melissano G, Bertoglio L, Rinaldi E, Leopardi M, Chiesa R. An anatomical review of spinal cord blood supply. J Cardiovasc Surg. 2015;56(5):699–706.

    CAS  Google Scholar 

  12. Riess KP, Gundersen SB, Ziegelbein KJ. Delayed neurologic deficit after infrarenal endovascular aortic aneurysm repair. Am Surg. 2007;73(4):385–7.

    PubMed  Google Scholar 

  13. Cho JS, Rhee RY, Makaroun MS. Delayed paraplegia 10 months after endovascular repair of thoracic aortic aneurysm. J Vasc Surg. 2008;47(3):625–8.

    Article  Google Scholar 

  14. Reid JA, Mole DJ, Johnston LC, Lee B. Delayed paraplegia after endovascular repair of abdominal aortic aneurysm. J Vasc Surg. 2003;37(6):1322–3.

    Article  Google Scholar 

  15. Goldstein LJ, Rezayat C, Shrikhande GV, Bush HL. Delayed permanent paraplegia after endovascular repair of abdominal aortic aneurysm. J Vasc Surg. 2010;51(3):725–8.

    Article  Google Scholar 

  16. Ministerio de Salud. Resolución número 8430 de 1993: Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. Accessed 29 Sept 2017.

  17. 2019 Asociación Médica Mundial. Declaración de Helsinki de la AMM - Principios Éticos para las Investigaciones Médicas en Seres Humanos. AMM; 2015.

Download references


Not applicable.


In relation to this article, the authors did not participate in any open calls or receive any financial support from their educational institution or from any other entity during the development of the study. Therefore, they did not receive any research funding, nor are they currently receiving any research funding; thus, there are no competing interests.

Author information

Authors and Affiliations



EP conceived of the case report; acquired, analyzed, and interpreted data; and wrote the case report. CC acquired, analyzed, and interpreted data and wrote the case report. CZ acquired, analyzed, and interpreted data. WS acquired, analyzed, and interpreted data. AB critically revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Erika D. Pérez-Riveros.

Ethics declarations

Ethics approval and consent to participate

Approval by the ethics committee was not necessary, because diagnostic procedures and treatments were performed according to standard clinical care [16]. The patient signed an institutional informed consent for receiving treatments.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images [17]. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pérez-Riveros, E.D., Cardona-Montes, C.A., Zapata-Álvarez, C.A. et al. Medullary ischemia after endovascular procedure of infrarenal aorta in a patient with dual anticoagulant and antiplatelet therapy: a case report. J Med Case Reports 13, 242 (2019).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: